NYSE
WLKP
Last Price
US $22.26
KEY FIGURES
MKT CAP
$0.8B
EPS
TTM
$3.60
PEG
TTM
0.04x
P/E
TTM
6.26x
P/S
TTM
0.68x
YIELD
8.32%
GROWTH
Revenue Y/Y
3.83%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $22.26
50.49%
Default assumptions
EBITDA Multiple
Fair Value
Market $22.26
256.20%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Westlake Chemical Partners LP cash flow to debt ratio of 70.17% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial risk - Healthy cash flow growth.
Westlake Chemical Partners LP's free cash flow has decreased -53.75% from $436.03M last year to $201.65M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Westlake Chemical Partners LP's debt to equity ratio is 0.80, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Westlake Chemical Partners LP's debt has increased relative to shareholder equity from 0.77 last year to 0.80 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
Westlake Chemical Partners LP has a net debt to EBITDA ratio of 0.79x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Westlake Chemical Partners LP's interest coverage ratio of 10.22 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Westlake Chemical Partners LP's profit margin has increased (88.20%) in the last year from 5.49% to 10.34%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Westlake Chemical Partners LP's short-term assets of $143.51M exceed its short-term liabilities of $51.30M
Increasing performance - ROA.
Westlake Chemical Partners LP's return on assets of 10.33% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Westlake Chemical Partners LP's return on equity of 25.43%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Westlake Chemical Partners LP's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Westlake Chemical Partners LP had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Westlake Chemical Partners LP has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Westlake Chemical Partners LP has a free cash flow yield of 25.25%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Westlake Chemical Partners LP's yearly earnings has increased 378.55% since last year from $62.39M to $298.58M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Westlake Chemical Partners LP's yearly revenue has increased 2.71% since last year from $1.14G to $1.17G, signaling increasing performance
Increasing performance - ROIC.
ROIC 30.03% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
Westlake Chemical Partners LP's 3-year revenue CAGR of -9.86% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Westlake Chemical Partners LP had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Westlake Chemical Partners LP had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Westlake Chemical Partners LP is undervalued relative to its fair value price of 33.50 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Westlake Chemical Partners LP has an earnings yield of 15.90%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Undervalued - EBITDA valuation.
Westlake Chemical Partners LP is undervalued relative to its fair value price of 79.29 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Westlake Chemical Partners LP has an EV/EBITDA ratio of 2.47x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Westlake Chemical Partners LP has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Westlake Chemical Partners LP has a price-to-book ratio of 1.61x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Westlake Chemical Partners LP has a price-to-sales ratio of 0.65x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
25.43%
Return on equity
ROIC: 30.03%
Valuation History
6.3X
Price to Earnings
EV/EBITDA: 2.5X
Cash flow
Profit margin
-0.30%
(FY vs FY)
Cash flow Y/Y
-9.73%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.